News Detail
New York, 9 Oct 2023 (IANS) Researchers have found elevated rates of high blood sugar, or hyperglycemia, among patients with breast cancer who are treated with the oral medication alpelisib.
Alpelisib targets the phosphoinositide 3-kinaseâ......
View Details
Source : IANS
hyperglycemia
oral medication alpelisib
Alpelisib targets the phosphoinositide 3-kinase (PI3K) protein
targeting PI3K can lead to hyperglycemia as a side effect
Related News
- IIT-BHU developing med device with potential to cure sclerosis (28-11-2024)
- Three widely used BP medicines Combo, five times more effective than current drugs (19-11-2024)
- More than half of patients with rheumatic, musculoskeletal disease use OTC supplements: Study (18-11-2024)
- One-third of older people and individuals admitted to the hospital experienced ADRs: Study (17-11-2024)
- Antithrombotic coating with sheltered positive charges prevents contact activation by controlling factor XII–biointerface binding (13-11-2024)
- IISc scientists develop enzyme-based solution to break antibiotic-resistant biofilms (13-11-2024)
- Japan performs world's first stem cell-treatment to restore vision (12-11-2024)
- Scientist treated her own cancer with viruses she grew in the lab (12-11-2024)
- Innovative use of silk in medical devices (10-11-2024)
- Three-fold throughput nitrosamine analysis in drug products using SIFT-MS (07-11-2024)